Related Experiment Videos
A study of buspirone coprescribed with histamine H2-receptor antagonists in anxious outpatients
1Oldham & District General Hospital, U.K.
International Clinical Psychopharmacology
|January 1, 1988
Abstract:
In a study of a large cohort of patients suffering from anxiety symptoms and treated with the new anxiolytic, buspirone, 0.5% were found to be receiving concomitant histamine H2-receptor antagonist therapy. A study of this subgroup showed that no drug interaction occurred.